Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Pediatr ; 239: 182-186, 2021 12.
Article in English | MEDLINE | ID: mdl-34450125

ABSTRACT

OBJECTIVE: To investigate treatment modalities for children with extremity indwelling catheter (EIC)- or cardiac catheter-related arterial thrombosis. STUDY DESIGN: The treatment of consecutive cases of catheter-related arterial thrombosis (CAT) at our institution between 2002 and 2017 was analyzed retrospectively. RESULTS: A total of 242 CATs developed in 224 children. Of these, 125 (52%) were EIC-related and 117 (48%) were cardiac catheter-related. Treatment included heparin alone in 60 cases (25%), acetylsalicyclic acid (ASA) alone in 6 cases (2%), heparin followed by ASA in 171 cases (71%), heparin followed by vitamin K antagonist (VKA) in 4 cases (1.5%), and VKA alone in 1 case (0.5%). Complete resolution of CAT was observed in 173 cases (71.5%), partial resolution in 13 cases (5.4%), and no resolution in 56 cases (23.1%). No statistical significance in the resolution rate was observed between treatment groups (P = .23). In 66% of cases, complete resolution occurred at a median of 18 days (range, 4-44 days) with heparin alone. A switch from heparin to ASA in children with partial or no resolution of CAT did not increase the resolution rate at follow-up. CONCLUSIONS: Heparin is an efficient treatment modality for CAT in pediatric patients. Long-term, subsequent treatment with ASA does not increase the resolution rate.


Subject(s)
Anticoagulants/therapeutic use , Cardiac Catheterization/adverse effects , Catheters, Indwelling/adverse effects , Femoral Artery , Fibrinolytic Agents/therapeutic use , Iliac Artery , Thrombosis/drug therapy , Adolescent , Aspirin/therapeutic use , Child , Child, Preschool , Drug Administration Schedule , Drug Therapy, Combination , Female , Follow-Up Studies , Heparin/therapeutic use , Humans , Infant , Infant, Newborn , Male , Retrospective Studies , Thrombosis/etiology , Treatment Outcome , Vitamin K/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL